Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating Population Variants and Protein Structural Analysis to Improve Clinical Genetic Diagnosis and Treatment in Nephrogenic Diabetes Insipidus. | Front Pediatr | 2021 | 33996673 | PubTator, text mining | PubMed |
| Cross Talk Between Renal Transporters and Polycystin-1 as a Potential Molecular Target Involved in Autosomal Dominant Polycystic Kidney Disease. | Iran J Kidney Dis | 2021 | 33994377 | PubTator, text mining | PubMed |
| Applications of Herbal Medicine to Treat Autosomal Dominant Polycystic Kidney Disease. | Front Pharmacol | 2021 | 33986666 | PubTator, text mining | PubMed |
| Nephrogenic syndrome of inappropriate antidiuresis - An ethnically, genetically and phenotypically diverse disorder: First report in a Chinese adult and review of published cases. | Clin Chim Acta | 2021 | 33984325 | PubTator, text mining | PubMed |
| Stem Cell Neurodevelopmental Solutions for Restorative Treatments of the Human Trunk and Spine. | Front Cell Neurosci | 2021 | 33981202 | PubTator, text mining | PubMed |
| Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease. | Sci Rep | 2021 | 33976330 | PubTator, text mining | PubMed |
| CESCR: CP-ABE for efficient and secure sharing of data in collaborative ehealth with revocation and no dummy attribute. | PLoS One | 2021 | 33974672 | PubTator, text mining | PubMed |
| Mechanisms of selective G protein-coupled receptor localization and trafficking. | Curr Opin Cell Biol | 2021 | 33965654 | PubTator, text mining | PubMed |
| Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation. | J Nephrol | 2021 | 33964006 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation. | Ther Adv Chronic Dis | 2021 | 33948157 | PubTator, text mining | PubMed |
| Histological and Immunohistochemical Characterization of Vomeronasal Organ Aging in Mice. | Animals (Basel) | 2021 | 33922332 | PubTator, text mining | PubMed |
| Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease. | Int J Mol Sci | 2021 | 33920158 | PubTator, text mining | PubMed |
| Regulation of Serum Sodium Levels during Chemotherapy Using Selective Arginine Vasopressin V2-Receptor Antagonist Tolvaptan in a Four-Year-Old Girl with a Suprasellar Germ Cell Tumor. | Children (Basel) | 2021 | 33920088 | PubTator, text mining | PubMed |
| Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives. | Cancers (Basel) | 2021 | 33916646 | PubTator, text mining | PubMed |
| Efficacy of oral tolvaptan for severe edema and hyponatremia in a patient with refractory nephrotic syndrome. | CEN Case Rep | 2021 | 33904139 | PubTator, text mining | PubMed |
| An infant with congenital nephrogenic diabetes insipidus presenting with hypercalcemia and hyperphosphatemia. | Endocrinol Diabetes Metab Case Rep | 2021 | 33899745 | PubTator, text mining | PubMed |
| Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2. | Nat Commun | 2021 | 33888704 | PubTator, text mining | PubMed |
| Constitutive G protein coupling profiles of understudied orphan GPCRs. | PLoS One | 2021 | 33886554 | PubTator, text mining | PubMed |
| Congenital nephrogenic diabetes insipidus accompanied with central nephrogenic diabetes secondary to pituitary surgery -a case report. | BMC Endocr Disord | 2021 | 33882907 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=41